Restoration of fragile histidine triad ( FHIT ) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines
- 12 March 2002
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (6) , 3615-3620
- https://doi.org/10.1073/pnas.062030799
Abstract
Loss of expression of the Fhit protein is often associated with the development of many human epithelial cancers, including lung and cervical carcinomas. Restoration of Fhit expression in cell lines derived from these tumors has however yielded conflicting results, prompting the need for careful evaluation of the oncosuppressive potential of FHIT. In the present study, we have investigated the effect of Fhit reintroduction in seven lung cancer and three cervical cancer cell lines. To achieve efficient gene transfer and high levels of transgene expression, we have used an adenoviral vector to transduce the FHIT gene. The induction of apoptosis was evaluated by using the terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay and propidium iodide staining. Activation of caspases was detected by using Western blot analysis, and tumorigenic potential of transduced cells in the nude mouse was also assessed. Restoration of Fhit expression induced apoptosis in all Fhit-negative cell lines, with Calu-1, H460, and A549 being the most susceptible among the lung cancer cell lines and SiHa cells among cervical carcinomas. Activation of caspase-8 was always associated with Fhit-mediated apoptosis, and in vivo tumorigenicity was either abolished by FHIT gene transfer (in H460 and SK-Mes cells) or strongly suppressed (in A549 and SiHa cells). Our data demonstrate oncosuppressive properties and strong proapoptotic activity of the Fhit protein in lung and cervical cancer cell lines and strengthens the hypothesis of its possible use as a therapeutic tool.Keywords
This publication has 21 references indexed in Scilit:
- Expression of truncated FHIT transcripts in cervical cancers and in normal human cellsOncogene, 2001
- Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.2001
- FHIT gene therapy prevents tumor development in Fhit-deficient miceProceedings of the National Academy of Sciences, 2001
- Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.2001
- Muir–Torre-like syndrome in Fhit-deficient miceProceedings of the National Academy of Sciences, 2000
- Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary BladderThe American Journal of Pathology, 2000
- Comparative allelotyping epithelial tumors of the short arm of human chromosome 3 in of four different typesFEBS Letters, 1999
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced ApoptosisJournal of Biological Chemistry, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996